Picture EBD Group Biotech Showcase 2024 San Francisco 650x100px

News > All

Total search results: 5466 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 ... 53 54 55  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases". Torino. 2023-02-22
Paleo B.V.. (2/22/23). "Press Release: Paleo Raises €12M to Bring the Real Taste of Meat to Plant-based Foods". Brussels. 2023-02-22
Endress+Hauser AG. (2/21/23). "Press Release: Endress+Hauser Initiates Generational Change. Dr Klaus Endress to Leave the Supervisory Board by the End of the Year; Matthias Altendorf Named as Successor; Dr Peter Selders Will Become CEO". 2023-02-21
CRISPR Therapeutics AG. (2/21/23). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results". Zug & Boston, MA. 2023-02-21
Friedrich-Alexander-Universität Erlangen-Nürnberg. (2/20/23). "Press Release: Testing Their Strength –CAR T-cells Combat Muscle Inflammation. Universitätsklinikum Erlangen the First in the World to Use a Pioneering New Method to Successfully Treat a Pati 2023-02-20
Alentis Therapeutics AG. (2/17/23). "Press Release: Alentis Therapeutics Makes Key Leadership Appointments". Basel. 2023-02-17
High-Tech Gründerfonds Management GmbH. (2/17/23). "Press Release: Selfapy Brings a Strategic Investor on Board". Berlin. 2023-02-17
Lift BioSciences Ltd.. (2/16/23). "Press Release: LIfT BioSciences and Minaris Regenerative Medicine Enter into a Manufacturing Partnership". London & Munich. 2023-02-16
Andera Partners. (2/16/23). "Press Release: Ahead of Its Business Plan, Andera Partners Approaches 4 Billion Euros in Assets Under Management and Announces a New 2028 Target of 6 to 8 Billion Euros". Paris. 2023-02-16
Panekès Partners SGR S.p.A.. (2/16/23). "Press Release: Panakès Partners Announces the Final Closing of the »Purple« Fund at 175 Million Euros". Milan. 2023-02-16
Epigenomics AG. (2/15/23). "Press Release: Epigenomics Decides to Restructure to Minimize Costs". Berlin & San Diego, CA. 2023-02-15
Qiagen N.V.. (2/14/23). "Press Release: Qiagen’s Tuberculosis Blood Test QuantiFERON-TB Gold Plus Gains CE-marking Under New EU IVDR Framework". Venlo. 2023-02-14
Hookipa Pharma Inc.. (2/13/23). "Press Release: Hookipa Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers". New York, NY & Vienna. 2023-02-13
Life Science Valley Ventures Management GmbH. (2/13/23). "Press Release: New Fund for Promoting Life Science Start-ups in Lower Saxony". Göttingen. 2023-02-13
Cydar Ltd.. (2/13/23). "Press Release: Cydar Medical Raises $11.5M (£9.3M) in Series A Funding Round". Cambridge. 2023-02-13
Hexagon Bio, Inc.. (2/13/23). "Press Release: Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived Small Molecules". Menlo Park, CA. 2023-02-13
Eppendorf SE. (2/13/23). "Press Release: New Production Site in Shanghai Metropolitan Region". Shanghai & Hamburg. 2023-02-13
Bayer AG. (2/13/23). "Press Release: Bayer Completes Acquisition of Blackford Analysis Ltd. [not intended for U.S. and UK Media]". Berlin. 2023-02-13
Evotec SE. (2/10/23). "Press Release: Evotec Receives € 150 m Loan from European Investment Bank". Hamburg & Toulouse. 2023-02-10
Freeline Therapeutics Holdings plc. (2/10/23). "Press Release: Freeline Announces Closing of Sale of Its CMC-focused German Subsidiary". London. 2023-02-10
BioNTech SE. (2/10/23). "Press Release: Pfizer and BioNTech Initiate Phase 1/2 Study of First mRNA-based Shingles Vaccine Program". New York, NY & Mainz. 2023-02-10
APK AG. (2/8/23). "Press Release: LyondellBasell and KIRKBI Invest in APK to Develop Recycling technology". Rotterdam, Billund & Merseburg. 2023-02-08
Spexis AG. (2/8/23). "Press Release: Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin (Ad hoc annuncement)". Allschwil. 2023-02-08
TVM Capital Life Science. (2/8/23). "Press Release: TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients". Montréal, QC & Munich. 2023-02-08
Icosagen AS. (2/8/23). "Press Release: InvestEU – EIB Agrees to a €18 Million Loan to Estonian Biotech Icosagen for Innovative R&D Technologies and New cGMP Production Facility". Tartu. 2023-02-08
BRAIN Biotech AG. (2/8/23). "Press Release: Structural Proteins for the Development of Sustainable Materials. BRAIN Biotech and AMSilk Cooperate to Develop High-performance Bio-based Protein Fibers". Zwingenberg & Neuried. 2023-02-08
Bayer AG. (2/8/23). "Press Release: Bill Anderson to Become CEO of Bayer AG". Leverkusen. 2023-02-08
BrainRepair UG. (2/8/23). "Press Release: Breakthrough – EUR 50 Million Investment for Start-up BrainRepair UG". Bochum. 2023-02-08
CureVac N.V.. (2/8/23). "Press Release: CureVac Announces Pricing of Upsized Public Offering of Common Shares". Tübingen & Boston, MA. 2023-02-08
Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA. 2023-02-07
Oxford Science Enterprises plc. (2/7/23). "Press Release: Oxford Science Enterprises Strengthens Life Sciences Investment Team with Appointment of Sanne de Jongh as Partner". Oxford. 2023-02-07
Qiagen N.V.. (2/7/23). "Press Release: Qiagen Exceeds Outlook for Fourth Quarter and Full-year 2022 with 14% CER Sales Growth in FY 2022 from Non-COVID Product Groups". Venlo. 2023-02-07
Formycon AG. (2/7/23). "Press Release: Enno Spillner Appointed Chief Financial Officer (CFO) of Formycon AG". Munich. 2023-02-07
Evotec SE. (2/7/23). "Press Release: Laetitia Rouxel to Succeed Enno Spillner as Chief Financial Officer". Hamburg. 2023-02-07
CureVac N.V.. (2/6/23). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA. 2023-02-06
Cellvie Inc.. (2/6/23). "Press Release: Cellvie Closes $5.5M of Additional Funding to Accelerate the Development of Therapeutic Mitochondria Transplantation". Tübingen & Boston, MA. 2023-02-06
APIS Assay Technologies Ltd.. (2/2/23). "Press Release: Clickmer Systems Receives €1.1m Grant to Deliver Innovative Diagnostic Platform for Fast Pandemic Responsiveness". 2023-02-02
BioNTech SE. (2/2/23). "Press Release: BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility". Mainz. 2023-02-02
Ariceum Therapeutics GmbH. (2/1/23). "Press Release: Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, M.D., as Chief Medical Officer". Berlin. 2023-02-01
Patient Square Capital L.P.. (2/1/23). "Press Release: Patient Square Capital Announces Record $3.9 Billion Inaugural Fund". Menlo Park, CA. 2023-02-01
Medigene AG. (2/1/23). "Press Release: Medigene AG Appoints Pamela Keck as Vice President of Investor Relations and Corporate Communications". Planegg. 2023-02-01
va-Q-tec AG. (1/30/23). "Press Release: Management and Supervisory Boards of va-Q-tec AG Recommend Acceptance of EQT Private Equity’s Voluntary Public Takeover Offer". Würzburg. 2023-01-30
Epigenomics AG. (1/27/23). "Press Release: Resignation of Supervisory Board Chairman Heino von Prondzynski". Berlin. 2023-01-27
Endress+Hauser AG. (1/27/23). "Press Release: Change at the Top of Analytik Jena. Ulrich Krauss Charts New Course; Oliver Klaeffling Set to Become Managing Director". 2023-01-27
Evotec SE. (1/26/23). "Press Release: Evotec Announces Agreement with Janssen to Develop Immune-based Therapies". Hamburg. 2023-01-26
High-Tech Gründerfonds Management GmbH. (1/26/23). "Press Release: Refined Laser Systems Raises €2.7m to Diagnose Cancer in Minutes". Münster. 2023-01-26
Co.don GmbH. (1/25/23). "Press Release: Co.don Finally Saved – Investor Has Taken Over the Business Operations of the Leipzig-based Biopharmacy Vompany with an Additional Location in Teltow, Brandenburg". Leipzig & Teltow. 2023-01-25
Rewind Therapeutics. (1/25/23). "Press Release: Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor". Leuven. 2023-01-25
Indivumed GmbH. (1/25/23). "Press Release: Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank". San Diego, CA & Hamburg. 2023-01-25
Novartis AG. (1/24/23). "Press Release: Sandoz Announces Agreement to Acquire Leading Antifungal Agent Mycamine from Astellas, Reinforcing Hospital Offering and Leading Anti-infectives Portfolio". Basel. 2023-01-24
Boehringer Ingelheim. (1/24/23). "Press Release: US FDA Accepts Supplemental New Drug Application for Jardiance for Adults with Chronic Kidney Disease". Ingelheim & Indianapolis, IN. 2023-01-24
Memo Therapeutics AG. (1/24/23). "Press Release: Memo Therapeutics AG Announces Positive Phase I Data with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients". Schlieren. 2023-01-24
Qiagen N.V.. (1/23/23). "Press Release: Qiagen Digital Insights Launches Ultra-fast NGS Analysis Able to Process a Whole Genome in 25 Minutes for a $1 in Cloud Computing Costs". Redwood City, CA & Hilden. 2023-01-23
TME Pharma N.V.. (1/23/23). "Press Release: TME Pharma Provides Clinical Update on the GLORIA Expansion Arm Testing NOX-A12 in Combination with Radiotherapy and Bevacizumab in Patients with Glioblastoma". Berlin. 2023-01-23
Bayer AG. (1/19/23). "Press Release: Bayer Launches New Collaboration with Oerth Bio to Further Advance Innovations in Crop Protection". Monheim & Durham NC. 2023-01-19
InSphero AG. (1/19/23). "Press Release: Brenus Pharma and InSphero Receive €1.5 Million in Grants from the European EUROSTARS Fund". Lyon & Schlieren. 2023-01-19
Biosynth AG. (1/19/23). "Press Release: Biosynth Hit 1M Products in Catalog. The Widest Catalog to Be the Leading Global Supplier". 2023-01-19
Bayer AG. (1/18/23). "Press Release: Bayer Acquires Blackford Analysis Ltd. Bolstering the company’s Position in Digital Medical Imaging [not intended for U.S. and UK Media]". Berlin. 2023-01-18
ASG Superconductors S.p.A.. (1/18/23). "Press Release: ASG Superconductors and Siemens Healthineers Join Forces to Deliver 10.5T Ultra High Field MRI Systems for Ground-breaking Brain Research". Genoa. 2023-01-18
Plasmion GmbH. (1/18/23). "Press Release: Plasmion and Agilent Technologies Announce Co-marketing Agreement to Provide Solutions for Life Sciences and Applied Chemical Markets". Augsburg. 2023-01-18
Medigene AG. (1/18/23). "Press Release: Medigene Receives $3 Million Milestone Payment from 2seventy bio". Planegg. 2023-01-18
Pureos Partners AG. (1/17/23). "Press Release: Pureos Partners Welcomes Dr. Ulf Grawunder to Its Team as Venture Partner". Pfäffikon. 2023-01-17
Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge. 2023-01-17
Ruhr-Universität-Bochum. (1/17/23). "Pressemitteilung: Alzheimer-Frühdiagnostik – Spin-Off BetaSense zieht ins BioMedizinZentrum". 2023-01-17
ImmunOs Therapeutics AG. (1/17/23). "Press Release: ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002". Schlieren. 2023-01-17
Ensilicated Technologies Ltd. (EnsiliTech). (1/17/23). "Press Release: Ensilicated Technologies Raises £1.2m to Develop Technology that Eliminates Need for Vaccine Refrigeration". Bristol. 2023-01-17
BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. 2023-01-17
Qiagen N.V.. (1/17/23). "Press Release: Qiagen Launches EZ2 Connect MDx Platform for Automated Sample Processing in". Venlo. 2023-01-17
TetraScience, Inc.. (1/12/23). "Press Release: Labforward Joins the Tetra Partner Network to Eliminate Data Silos and Error-Prone Data Transfers". Boston, MA. 2023-01-12
Bayer AG. (1/11/23). "Press Release: Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power". Berlin & Sunnyvale, CA. 2023-01-11
ProBioGen AG. (1/10/23). "Press Release: ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck Transposase Technology". Berlin. 2023-01-10
CureVac N.V.. (1/10/23). "Press Release: CureVac Appoints Alexander Zehnder as CEO from April 1, 2023". Mainz & London. 2023-01-10
Sernova Corporation. (1/10/23). "Press Release: Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes". London, ON. 2023-01-10
BioNTech SE. (1/10/23). "Press Release: BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development". Mainz & London. 2023-01-10
Medios AG. (1/10/23). "Press Release: Medios AG. Successful Completion of the Acquisition of bbw – Significant Expansion of Compounding Volume". Berlin. 2023-01-10
Bayer AG. (1/10/23). "Press Release: NextPoint Therapeutics Announces $80 Million Series B Financing Co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs". Cambridge, MA & Leverkusen. 2023-01-10
Idorsia Ltd.. (1/9/23). "Press Release: Idorsia Presents at the 41st J.P. Morgan Healthcare Conference – Achievements in 2022 Provide the Foundation for Our Success in 2023". Allschwil. 2023-01-09
Alentis Therapeutics AG. (1/9/23). "Press Release: Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1". Basel. 2023-01-09
Qiagen N.V.. (1/9/23). "Press Release: Qiagen Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics with NGS Technologies". Venlo & San Diego, CA. 2023-01-09
Proteros Biostructures GmbH. (1/9/23). "Press Release: Proteros Receives Minority Investment from Private Equity Firm Inflexion". Martinsried. 2023-01-09
Boehringer Ingelheim. (1/9/23). "Press Release: Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies". Ingelheim & South San Francisco, CA. 2023-01-09
BioNTech SE. (1/6/23). "Press Release: BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030". Mainz. 2023-01-06
CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA. 2023-01-06
BioVersys AG. (1/5/23). "Press Release: BioVersys Extends Its Series C Round to CHF 32.6 Million with investment from the AMR Action Fund". Basel. 2023-01-05
Bruker Corporation. (1/5/23). "Press Release: Bruker Announces Acquisition of Acquifer Imaging GmbH". Heidelberg. 2023-01-05
ADC Therapeutics S.A.. (1/4/23). "Press Release: ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference". Lausanne. 2023-01-04
Hookipa Pharma Inc.. (1/4/23). "Press Release: Hookipa Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine". New York, NY & Vienna. 2023-01-04
Bruker Corporation. (1/4/23). "Press Release: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers". Lausanne. 2023-01-04
Ethris GmbH. (12/29/22). "Press Release: Cipla EU to Invest EUR 15 million in Ethris, Initiating a Strategic Collaboration". Mumbai & Munich. 2022-12-29
BioNTech SE. (12/28/22). "Press Release: BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference". Mainz. 2022-12-28
BioNTech SE. (12/23/22). "Press Release: BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165". Mainz. 2022-12-23
aws Gründerfonds. (12/23/22). "Pressemitteilung: aws Gründerfonds investiert in nachhaltiges Lebensmittel-Startup Arkeon". Tulln & Wien. 2022-12-23
Merck KGaA. (12/22/22). "Press Release: Merck Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates". Darmstadt. 2022-12-22
Ryvu Therapeutics S.A.. (12/22/22). "Press Release: Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds over PLN 250 Million". Krakow. 2022-12-22
MDG Molecular Diagnostics Group GmbH. (12/21/22). "Press Release: Molecular Diagnostics Group and Swiss 4D Lifetec AG Become Strategic Partners". 2022-12-21
Ethris GmbH. (12/21/22). "Press Release: Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses". Munich. 2022-12-21
BioNTech SE. (12/21/22). "Press Release: BioNTech Starts Phase 1 Clinical Trial for Prophylactic Herpes Simplex Virus-2 Vaccine Candidate BNT163". Mainz. 2022-12-21
Bruker Corporation. (12/21/22). "Press Release: Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference". Billerica, MA. 2022-12-21
ADC Therapeutics S.A.. (12/21/22). "Press Release: ADC Therapeutics and Sobi Announce European Commission Approval of Zynlonta (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma". Lausanne. 2022-12-21
BioNTech SE. (12/21/22). "Press Release: Update on First BioNTainer for African-based mRNA Manufacturing Facility". Mainz. 2022-12-21
next pagenext page 1 2 3 4 5 6 ... 53 54 55  next pagenext page


Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner Join Cluster HealthCapital Berlin Brandenburg 650x300px

» top